Literature DB >> 31084545

Importance of Assessing Patient-Reported Outcomes With Salvage Autologous Transplantation in Relapsed Multiple Myeloma.

Bronwen E Shaw1, Anita D'Souza1, Stephanie J Lee2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31084545      PMCID： PMC6879316          DOI： 10.1200/JCO.19.00865

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma.

Authors:  Rajshekhar Chakraborty; Betty K Hamilton; Shahrukh K Hashmi; Shaji K Kumar; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-04       Impact factor: 5.742

2.  Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.

Authors:  Melanie Calvert; Jane Blazeby; Douglas G Altman; Dennis A Revicki; David Moher; Michael D Brundage
Journal:  JAMA       Date:  2013-02-27       Impact factor: 56.272

3.  Methodological aspects of health-related quality of life measurement and analysis in patients with multiple myeloma.

Authors:  Lene Kongsgaard Nielsen; Niels Abildgaard; Mary Jarden; Tobias Wirenfeld Klausen
Journal:  Br J Haematol       Date:  2019-01-17       Impact factor: 6.998

4.  Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review.

Authors:  Francesco Sparano; Michele Cavo; Pasquale Niscola; Tommaso Caravita; Fabio Efficace
Journal:  Support Care Cancer       Date:  2018-03-20       Impact factor: 3.603

5.  The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.

Authors:  Gordon Cook; A John Ashcroft; David A Cairns; Cathy D Williams; Julia M Brown; Jamie D Cavenagh; John A Snowden; Christopher Parrish; Kwee Yong; Jim Cavet; Hannah Hunter; Jenny M Bird; Guy Pratt; Sally Chown; Ernest Heartin; Sheila O'Connor; Mark T Drayson; Anna Hockaday; Treen C M Morris
Journal:  Lancet Haematol       Date:  2016-07       Impact factor: 18.959

6.  Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

Authors:  Melanie Calvert; Derek Kyte; Rebecca Mercieca-Bebber; Anita Slade; An-Wen Chan; Madeleine T King; Amanda Hunn; Andrew Bottomley; Antoine Regnault; An-Wen Chan; Carolyn Ells; Daniel O'Connor; Dennis Revicki; Donald Patrick; Doug Altman; Ethan Basch; Galina Velikova; Gary Price; Heather Draper; Jane Blazeby; Jane Scott; Joanna Coast; Josephine Norquist; Julia Brown; Kirstie Haywood; Laura Lee Johnson; Lisa Campbell; Lori Frank; Maria von Hildebrand; Michael Brundage; Michael Palmer; Paul Kluetz; Richard Stephens; Robert M Golub; Sandra Mitchell; Trish Groves
Journal:  JAMA       Date:  2018-02-06       Impact factor: 56.272

7.  Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives.

Authors:  Julie Rouette; Jane Blazeby; Madeleine King; Melanie Calvert; Yingwei Peng; Ralph M Meyer; Jolie Ringash; Melanie Walker; Michael D Brundage
Journal:  Qual Life Res       Date:  2014-11-29       Impact factor: 4.147

8.  Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry.

Authors:  Rafat Abonour; Lynne Wagner; Brian G M Durie; Sundar Jagannath; Mohit Narang; Howard R Terebelo; Cristina J Gasparetto; Kathleen Toomey; James W Hardin; Amani Kitali; Craig J Gibson; Shankar Srinivasan; Arlene S Swern; Robert M Rifkin
Journal:  Ann Hematol       Date:  2018-07-29       Impact factor: 3.673

9.  Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.

Authors:  Sam H Ahmedzai; John A Snowden; Andrew John Ashcroft; David Allan Cairns; Cathy Williams; Anna Hockaday; Jamie D Cavenagh; Debo Ademokun; Eleni Tholouli; David Allotey; Vijay Dhanapal; Matthew Jenner; Kwee Yong; Jim Cavet; Hannah Hunter; Jennifer M Bird; Guy Pratt; Christopher Parrish; Julia M Brown; Treen C M Morris; Gordon Cook
Journal:  J Clin Oncol       Date:  2019-04-10       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.